Unique ID issued by UMIN | UMIN000019062 |
---|---|
Receipt number | R000021449 |
Scientific Title | A long term assessment for factors having an impact on the patency of saphenous vein graft following coronary artery bypass grafting |
Date of disclosure of the study information | 2015/09/18 |
Last modified on | 2015/09/27 20:46:15 |
A long term assessment for factors having an impact on the patency of saphenous vein graft following coronary artery bypass grafting
A long term assessment for factors having an impact on the patency of saphenous vein graft following coronary artery bypass grafting
A long term assessment for factors having an impact on the patency of saphenous vein graft following coronary artery bypass grafting
A long term assessment for factors having an impact on the patency of saphenous vein graft following coronary artery bypass grafting
Japan |
Ischemic cardiac disease(effort angina pectoris,asymptomatic myocardial ischemia,acute coronary syndrome
Cardiology | Vascular surgery |
Others
NO
One of two aims is to clarify risk factors associated with the occlusion of vein graft by evaluating patient characteristics, pathological finding and blood flow velocity of vein graft, intravascular image by optical coherence tomography (OCT), inflammatory and vasoactive biomarker in the patient underwent coronary bypass grafting (CABG) using the vein graft,
The other is to detect graft failures one year after CABG by graftgraphy even if the subject with silent myocardial ischemia. And, adequate medical intervention can be provided by revascularization or optimal medical therapy.
Efficacy
The patency of saphenous vein graft one year after CABG
1) Lumen area, intimal thickening and incidence of thrombus evaluated by OCT
2) Coronary flow velocity of saphenous vein graft
3) Value of inflammatory and vasoactive biomarker
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Patients meeting all of the following conditions will be included:
1) underwent coronary bypass grafting using the vein graft
2) between 20 and 85 years old
3) written consent for participation in the study
Patients meeting one of the following conditions will be excluded:
1) severe liver dysfunction
2) renal dysfunction (Cre>= 2.0mg/dL)
3) severe heart failure (NYHA/New York Heart Association stage III or severer)
4) malignancies or other diseases with poor prognosis
5) pregnant, lactating, and possibly pregnant women and those planning to become pregnant
6) judged as ineligible by clinical investigators
25
1st name | |
Middle name | |
Last name | Toshiro Shinke |
Kobe University Graduate School of Medicine
Division of Cardiovascular Medicine
7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan
078-382-5111
shinke@med.kobe-u.ac.jp
1st name | |
Middle name | |
Last name | Yuichiro Nagano |
Kobe University Graduate School of Medicine
Division of Cardiovascular Medicine
7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan
078-382-5111
y_nagano1981@yahoo.co.jp
Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine
Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine
Self funding
NO
2015 | Year | 09 | Month | 18 | Day |
Unpublished
Open public recruiting
2015 | Year | 08 | Month | 01 | Day |
2015 | Year | 10 | Month | 01 | Day |
This is cohort study for evaluating risk factors of graft occlusion at the mid term follow-up after CABG.
2015 | Year | 09 | Month | 18 | Day |
2015 | Year | 09 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021449